(MENAFN- GlobeNewsWire - Nasdaq) MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results